Product Code: ETC336024 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India organs on chips (OoC) market was valued at USD 257 thousand in 2025 and is expected to reach USD 474 thousand by 2031; thus registering a CAGR of 10.6%. Growing demand from the research sector coupled with growing government support towards healthcare advancements are among some factors that have driven the growth of this industry significantly over recent years. In addition to this, technological advancements made in OoCs have enabled researchers to use them more effectively than before thus providing an impetus for their adoption rates across various sectors including pharma/biotech laboratories and academia/research institutes among others.
The India organ on a chip market is driven by advancements in medical research and the pursuit of alternatives to traditional animal testing. Organ on a chip technology holds promise for drug testing, disease modeling, and personalized medicine. The growing focus on precision medicine and the need to minimize ethical concerns related to animal testing propel the adoption of this technology. Collaborations between research institutions, pharmaceutical companies, and regulatory bodies further drive the market. However, the complexity of replicating organ functions on a chip and the associated technological challenges are important factors that influence market growth.
The organ-on-a-chip market in India is at the intersection of technology and healthcare, offering promising advancements. However, challenges such as the complexity of recreating accurate organ functionality on a chip and the need for collaboration between various scientific disciplines pose hurdles. The market also requires substantial investments in research and development to refine these technologies and validate their efficacy in drug testing and disease modeling.
The India organ on a chip market has been gradually evolving with advancements in biotechnology and pharmaceutical research. These devices replicate the functions of human organs, aiding drug testing and disease modeling. The pandemic highlighted the importance of innovative research tools, but disruptions in supply chains and research activities impacted the market`s growth. As research activities normalize and healthcare industries invest in cutting-edge technologies, the organ on a chip market is expected to witness renewed interest, contributing to advancements in drug discovery and personalized medicine.
In the realm of advanced medical research, the India organ on a chip market is gaining traction. Notable players like Emulate, Inc. are at the forefront of developing innovative organ-on-a-chip technologies. These technologies have the potential to revolutionize drug testing, disease modeling, and personalized medicine. As the demand for efficient and accurate in vitro models increases, key players in the biotechnology and healthcare sectors are expected to contribute significantly to the growth and adoption of organ-on-a-chip platforms in India.